本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mirum Pharmaceuticals, Inc.

91.83
-6.9900-7.07%
盤後91.830.00000.00%19:30 EDT
成交量:179.80萬
成交額:1.66億
市值:59.63億
市盈率:-6.52
高:98.76
開:98.76
低:91.73
收:98.82
52周最高:130.00
52周最低:63.23
股本:6,493.22萬
流通股本:5,641.51萬
量比:2.36
換手率:3.19%
股息:- -
股息率:- -
每股收益(TTM):-14.0800
每股收益(LYR):-0.4700
淨資產收益率:-702.97%
總資產收益率:-6.79%
市淨率:-572.13
市盈率(LYR):-195.38

資料載入中...

2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/27

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/27

重要事件披露

Form 8-K - Current report
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/08

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities